Arno Schönberger

Title: Arno Schönberger: Innovator in Biotechnological Advancements

Introduction

Arno Schönberger is a notable inventor based in Hamburg, Germany. He has made significant contributions to the field of biotechnology, particularly in the diagnosis and therapy of systemic lupus erythematosus (SLE). His innovative work has the potential to improve the lives of many patients suffering from this autoimmune disease.

Latest Patents

Arno Schönberger holds a patent for "Peptides for the production of preparations for the diagnosis and therapy of systemic lupus." This patent involves peptides that contain antigenic or immunogenic determinants derived from autoantibodies found in the body fluids of SLE patients. Specifically, the invention focuses on the C terminus of H1 with the sequence section 187-211 and the N termini of H2B with the sequence sections 1-35 and 36-76. These peptides are capable of cross-reactions with anti-histone antibodies. The invention also outlines methods for forming monoclonal antibodies and anti-idiotypical antibodies directed against these autoantibodies. This advancement allows for a highly certain diagnosis of SLE and provides a foundation for developing medicaments for its therapy.

Career Highlights

Arno Schönberger is associated with Symbiotec Gesellschaft zur Erforschung und Entwicklung auf dem Gebiet der Biotechnologie mbH. His work at this company has been instrumental in advancing biotechnological research and applications.

Collaborations

He has collaborated with notable colleagues, including Michael Zeppezauer and Ladislav Cebecauer, contributing to the innovative research environment at Symbiotec.

Conclusion

Arno Schönberger's contributions to biotechnology, particularly in the context of systemic lupus erythematosus, highlight his role as a key innovator in the field. His patent and collaborative efforts pave the way for advancements in diagnosis and therapy for autoimmune diseases.